ABCL
AbCellera Biologics·NASDAQ
--
--(--)
--
--(--)
ABCL fundamentals
AbCellera Biologics (ABCL) released its earnings on Feb 24, 2026: revenue was 44.90M (YoY +780.39%), beat estimates; EPS was -0.03 (YoY +75.00%), beat estimates.
Revenue / YoY
44.90M
+780.39%
EPS / YoY
-0.03
+75.00%
Report date
Feb 24, 2026
Earnings Call
5:00 PM on Feb 24, 2026
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
ABCL has released its 2025 Q4 earnings report, with revenue of 44.85M, reflecting a YoY change of 788.18%, and net profit of -8.95M, showing a YoY change of 73.85%. The Sankey diagram below clearly presents ABCL's revenue sources and cost distribution.
Key Indicators
AbCellera Biologics (ABCL) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
AbCellera Biologics (ABCL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
AbCellera Biologics (ABCL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
AbCellera Biologics (ABCL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does AbCellera Biologics (ABCL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track AbCellera Biologics (ABCL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for AbCellera Biologics year over year?What does AbCellera Biologics do and what are its main business segments?What is AbCellera Biologics's gross profit margin?What guidance did AbCellera Biologics's management provide for the next earnings period?What were the key takeaways from AbCellera Biologics’s earnings call?What is AbCellera Biologics's latest dividend and current dividend yield?What were the key takeaways from AbCellera Biologics's earnings call?What is the market's earnings forecast for AbCellera Biologics next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
